Shares of eight pharma companies rose by 0.03% to 1.14% at 10:25 IST on BSE after a further drop in rupee against the dollar.
Meanwhile, the S&P BSE Sensex was down 4.13 points or 0.06% at 24,757.61.
Sun Pharmaceutical Industries (up 0.37%), Alembic Pharmaceuticals (up 0.8%), Dr Reddy's Laboratories (up 0.73%), Glenmark Pharmaceuticals (up 0.38%), Venus Remedies (up 1.27%), Pfizer (up 0.07%), Novartis India (up 0.03%), and Cadila Healthcare (up 1.14%) gained. Cipla (down 0.07%) and Lupin (down 1.04%) declined.
Weakness in rupee could boost sales of pharma companies in rupee terms as pharma firms derive substantial revenue from exports.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 67.3675, compared with its close of 67.29 during the previous trading session.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app